Jonathan B. Siegel serves as Executive at Jaguar Health, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan B. Siegel has executed 10 insider transactions totaling $59.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 11, 2025 involved receiving (via award) 7,377 shares valued at $0.
Jonathan B. Siegel currently holds 7,423 shares of Jaguar Health, Inc. (JAGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan B. Siegel has been a net buyer of JAGX stock. They have purchased $59.1K and sold $0 worth of shares.
Jonathan B. Siegel's most recent insider trade was on Dec 11, 2025, when they sold 7,377 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 17, 2023 | JAGX | $0 | Option Exercise | 1,145 | $N/A | Discretionary |
| May 18, 2022 | JAGX | $0 | Option Exercise | 12,133 | $N/A | Discretionary |
| Jul 23, 2019 | JAGX | $25.4K | Purchase | 12,705 | $2.00 | Discretionary |
| Oct 4, 2018 | JAGX | $15.0K | Purchase | 25,000 | $0.60 | Discretionary |
| Jul 18, 2018 | JAGX | $5.5K | Purchase | 5,000 | $1.10 | Discretionary |
| Jul 17, 2018 | JAGX | $319 | Purchase | 268 | $1.19 | Discretionary |
| Jul 17, 2018 | JAGX | $2.7K | Purchase | 2,232 | $1.19 | Discretionary |
| Jul 16, 2018 | JAGX | $10.2K | Purchase | 7,500 | $1.36 | Discretionary |